OncoPSM: an interactive tool for cost-effectiveness analysis using partitioned survival models in oncology trial
IntroductionCost-effectiveness analysis (CEA) serves as a critical tool to evaluate the economic sustainability of new treatments. However, many CEA tools are not specifically tailored to address the intricate cost composition resulting from the complex treatment regimens in oncology trials.MethodsW...
Saved in:
| Main Authors: | Xulong Qiu, Jidi Chen, Muting Wang, Kaixin Zheng, Ruixiong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1554405/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal control and cost-effectiveness analysis of Q-fever transmission dynamics in livestock and humans
by: Nkuba Nyerere, et al.
Published: (2025-09-01) -
Cost-utility analysis of omalizumab for the treatment of chronic spontaneous urticaria in China
by: Yueyang Huang, et al.
Published: (2025-07-01) -
Cost effectiveness of mono, dual, and triple therapy of antihypertensive drugs: a retrospective cohort study
by: Abdullah, et al.
Published: (2025-08-01) -
Cost-effectiveness of pertussis booster vaccination of 6-year-old children
by: A. V. Rudakova, et al.
Published: (2025-03-01) -
Value of Vaccinations: A Fundamental Public Health Priority to Be Fully Evaluated
by: Sara Boccalini
Published: (2025-04-01)